June 08, 2011, Hyderabad: In an agreement facilitated by the Indiana Economic Development
Corporation (IEDC) during a February economic mission to India, the Indiana Clinical and Translational
Sciences Institute (CTSI) has partnered with GVK Biosciences, Asia’s leading Contract Research
Organization, to provide researchers across the United States access to GVK BIO’s Clinical Biomarker
Database that will advance research on wide range of diseases. The Indiana CTSI Bioinformatics Core
and Indiana Institute for Personalized Medicine will work together to manage the process by which
researchers access this new resource.
The GVK Biosciences Clinical Biomarker Database known as (GOBIOM) is a comprehensive collection of
all clinically evaluated, exploratory and preclinical biomarkers associated with different therapeutic
areas reported in global clinical trials, clinical and preclinical studies. The resource will be available
nationwide to 55 medical centers and universities supported by the Clinical and Translational Sciences
Award from the National Institutes of Health.
“The GOBIOM database is a powerful tool for clinicians and researchers looking to mine the most up to
date and comprehensive information about any putative biomarker for personalized therapeutics,” said
Anantha Shekhar, director of the Indiana CTSI. “The Indiana CTSI is very pleased to partner with GVK BIO
and the Indiana Institute for Personalized Medicine to make this resource available to all clinical and
translational researchers in the national consortium. I am also grateful to the Indiana Economic
Development Corporation for facilitating the GVK BIO and CTSI partnership.”
“GVK BIO is pleased that the Indiana CTSI chose the GVK BIO Biomarker Database for its research efforts.
Biomarker research is increasing at a rapid pace and the database is designed to help researchers keep
pace with the latest data. We look forward to collaborating with the CTSI and further improving the
product to address the needs of the researchers and reviewers,” said Sreeni Devidas, Ph.D., vice
president for sales and marketing in informatics at GVK Biosciences.
“From research and development to commercialization, Indiana’s wealth of expertise in life sciences
has improved the knowledge and quality of medicine for researchers and patients around the world. The
partnership between GVK Biosciences and the Indiana CTSI sprung from initial meetings during our
February economic mission to India and has quickly developed into a tangible partnership that could be
the precursor for future global opportunities,” said Mitch Roob, secretary of commerce and chief
executive officer of IEDC. GOBIOM contains information on 12,000 biomarkers comprising biochemical,
genomic, imaging, metabolite, cellular and physiological markers with multiple data points covering
experimental, analytical, clinical and statistical data with their qualifications under different medical interventions. The GOBIOM database contains the latest and updated information on all the biomarkers
reported in various clinical and preclinical studies.
About Indiana CTSI
The Indiana Clinical and Translational Sciences Institute (CTSI) is a statewide collaboration of Indiana
University, Purdue University and the University of Notre Dame, as well as public and private
partnerships, which facilitates the translation of scientific discoveries in the lab into new patient
treatments in Indiana and beyond. Established in 2008 with a $25 million Clinical and Translational
Science Award (CTSA) from National Institutions of Health, supplemented by nearly $60 million from the
state, the three member universities, and public and private partners, the Indiana CTSI is a member of a
national network of 55 CTSA-funded organizations across the United States. For more information, visit
www.indianactsi.org.
About GVK Biosciences
GVK Biosciences Private Limited (GVK BIO) is Asia’s leading Discovery Research and Development
organization. GVK BIO provides a broad spectrum of services, stand-alone and integrated, across the
R&D value chain. Our discovery services consist of Chemistry, Biology and Informatics; the development
services include Clinical Research, Clinical Pharmacology and Process R&D. GVK BIO’s diverse portfolio of
more than 150 customers includes some of the world’s largest pharmaceutical, biotechnology, agro, life-
sciences companies and leading academic institutions. Please visit us at www.gvkbio.com to know more.
Contacts:
For any further information, please contact:
Sreeni Devidas
Vice President – Sales & Marketing, Informatics
GVK Biosciences Private Limited
Columbia, MD 21045
T (443)-838-6260
E sreeni.devidas@gvkbio.com
Sharada Alvakonda
Dy General Manager – Corporate Communications
GVK Biosciences Private Limited
Hyderabad
T +91 40 66929999
F +91 40 66929900
E sharada@gvkbio.com